Horizontal pleiotropy, where one variant has independent effects on multiple traits, is important 23 for our understanding of the genetic architecture of human phenotypes. We developed a 24 method to quantify horizontal pleiotropy using genome-wide association summary statistics and 25 applied it to 372 heritable phenotypes measured in 361,194 UK Biobank individuals. We 26 observed horizontal pleiotropy is: 1) pervasive throughout the human genome; 2) especially 27 prominent among highly polygenic phenotypes; 3) detected in 24,968 variants in 7,831 loci; and 28 4) enriched in active regulatory regions. Our results highlight the central role horizontal 29 pleiotropy plays in the genetic architecture of human phenotypes. 30
Background

33
The term "pleiotropy" refers to a single genetic variant having multiple distinct phenotypic 34 effects. In general terms, the existence and extent of pleiotropy has far-reaching implications on 35 our understanding of how genotypes map to phenotypes (1) , of the genetic architectures of 36 traits (2,3), of the biology underlying common diseases (4) and of the dynamics of natural 37 selection (5). However, beyond this general idea of the importance of pleiotropy, it quickly 38 becomes difficult to discuss in specifics, because of the difficulty in defining what counts as a 39 direct causal effect and what counts as a separate phenotypic effect. 40
One particularly important dividing line in these conflicting definitions is the distinction between 41 vertical pleiotropy and horizontal pleiotropy (6,7). When a genetic variant has a phenotypic 42 effect that then has its own downstream effects in turn, that variant exhibits "vertical" pleiotropy. 43 of variants to formulate a statistical test for causal relationships among traits, which is now 91 widely used for biological discovery (14, 15) . We extend this methodology to use the entire set of 92 SNVs evaluated by GWAS, treating a GWAS-wide correlation between two traits as evidence of 93 a vertical pleiotropic relationship between these traits. 94
In the case of horizontal pleiotropy, an individual variant acts on traits A and B without mirroring 95 any trait-level relationship between them. Unlike vertical pleiotropy, since we are not considering 96 the variant-level effect as evidence of a relationship between the two traits, we cannot detect 97 horizontal pleiotropy by detecting correlations between traits. Instead, each horizontally 98 pleiotropic variant acts by its own unique mechanism. These particular pleiotropic variants, 99 therefore, should show a relationship between the two traits that deviates from the relationship 100 we would infer from the genome-wide correlation of effect sizes between them. This deviation 101 from the correlation between traits is not a prediction of any kind of model of pleiotropy, but 102 simply follows from our definition of the term "horizontal pleiotropy": any pair of traits whose 103 effect sizes are correlated across all variants is by definition related by vertical pleiotropy, while 104 any variant whose effects on two traits substantially deviate from the trait-level relationship 105 between those traits is by definition exhibiting horizontal pleiotropy. 106 A quantitative score for pleiotropy 107 We have developed a method to measure horizontal pleiotropy using summary statistics data 108 from GWASs on multiple traits. Our method relies on applying a statistical whitening procedure 109 to a set of input variant-trait associations, which removes correlations between traits caused by 110 vertical pleiotropy and normalizes effect sizes across all traits. Using the decorrelated 111 association Z-scores, we measure two related but distinct components of pleiotropy: the total 112 magnitude of effect on whitened traits ("magnitude" score, denoted ܲ ) and the total number of 113 whitened traits affected by a variant ("number of traits" score, denoted ܲ ሻ . Both scores are then 114 traits, but the effects of each variant on each trait are independent and the number of 138 variants with effects on multiple traits is no more than would be expected by chance. 139
This empirical correction for polygenicity is required because polygenicity is a major factor that 140 can produce pleiotropy. For example, it has been estimated that approximately 100,000 141 independent loci are causal for height in humans (16) . If the total number of independent loci in 142 the human genome is approximately 1 million, this corresponds to about 10% of the human 143 genome having an effect on height. If we imagine multiple phenotypes with this same highly 144 polygenic genetic architecture, we should expect substantial overlap between causal loci for 145 multiple different traits, even in the absence of any true causal relationship between the traits, 146 resulting in horizontal pleiotropy (Figure 2) . 147
Power to detect pleiotropy in simulations 148 We conducted a simulation study to evaluate the performance of our two-component pleiotropy 149 score. We simulated 800,000 variants controlling 100 traits, varying the per-trait liability scale 150 heritability of all traits ݄ ଶ and the proportion of pleiotropic and non-pleiotropic causal variants. To 151 introduce LD in the simulations, we used real LD architecture from 800000 SNVs from 1000 152 Genomes European population. We simulated Z-scores independently for each SNV and then 153 propagate LD for a given SNV by "contaminating" its Z-score according to the Z-scores of the 154 SNVs in LD with it. Under the null model, all trait-variant associations were independent, and no 155 horizontal pleiotropy was added. Under the added-pleiotropy models, we randomly chose a 156 fraction of causal variants and forced them to have simultaneous associations with multiple 157 traits. The simulation study showed that both components of the pleiotropy score were well-158 powered to detect horizontal pleiotropy (Figure 4) , and that the LD correction dramatically 159 reduces the dependence of the pleiotropy score on LD (Supplementary Figure 1) In the presence of both pleiotropic and non-pleiotropic causal variants, detecting pleiotropy was 169 more difficult, but our approach still had appreciable power to detect pleiotropic variants, which 170 increased with increasing per-variant heritability and decreased with increasing numbers of non-171 pleiotropic causal variants. Adding the correction for polygenic architecture (ܲ ݉ ܲ and ܲ ݊ ܲ ) 172 reduced this power only slightly. The power of our method was not substantially reduced by 173 increasing the number of traits affected by pleiotropic variants (Supplementary Figure 2) or by 174 adding a realistic correlation structure between the traits (Supplementary Figure 3) . 175 To apply our method to real human association data, we used GWAS association statistics for 178 372 heritable medical traits measured in 337,119 individuals from the UK Biobank (17-19) . We 179 successfully computed our two-component pleiotropy score for 767,057 variants genome-wide 180 and conducted a genome-wide pleiotropy study (GWPS), by analogy to a standard GWAS 181 Figure 6) . 189 As an additional test of whether the pleiotropy we observe is driven by polygenicity, we 200 calculated the polygenicity of the same 372 heritable traits from the UK Biobank. We measured 201 polygenicity using a version of the genomic inflation factor corrected using LD score ߣ ீ (20) . 202
Genome-Wide Pleiotropy Study (GWPS) reveals pervasive
Pleiotropy is driven by polygenicity
We then stratified these traits by ߣ ீ after controlling for heritability (Methods), and calculated 203 the two-component LD-corrected pleiotropy score [ܲ and ܲ ሿ ) and P-values for each 204 component independently for every variant in the genome using each of these bins of traits. We 205 observed that both scores are highly dependent on polygenicity, with the lowest-polygenicity 206 bins in each heritability class showing very little inflation. (Figure 5 ; Supplementary Table 1) . 207
Taken together, these results suggest that extreme polygenicity drives horizontal pleiotropy, and 208 that this has an extremely large effect on the genetic architecture of human phenotypes. 209
Genome-wide distribution of pleiotropy score gives insight into 210 genetic architecture 211 In addition to observing genome-wide inflation of the pleiotropy score, we can also gain insight 212 from the distribution of the pleiotropy score on a more granular level. 213 observed that both components of the pleiotropy score are higher on average in transcribed 226 regions (coding and UTR) than in intergenic noncoding regions. This result was confirmed and 227 expanded by annotations from Roadmap Epigenomics (22), which showed that regions whose 228 chromatin configurations were associated with actively transcribed regions, promoters, 229 enhancers, and transcription factor binding sites had significantly higher levels of both 230 components of the pleiotropy score, while heterochromatin and quiescent chromatin states had 231 significantly lower levels. Investigating individual histone marks, we found that both the 232 repressive histone mark H3K27me3 and the activating histone mark H3K27ac were associated 233 with elevated levels of pleiotropy, although the activating mark H3K27ac had a larger effect. 234
This may indicate that being under active regulation at all produces higher levels of pleiotropy, 235 whether that regulation is repressive or activating. 236
We also used data from the Genotype-Tissue Expression (23) project to measure the 237 connection between transcriptional effects and our pleiotropy score ( Table 1) . Consistent with 238 the previous observation that functional regions had higher pleiotropy scores, we found that 239 variants that were identified as cis-eQTLs for any gene in any tissue had higher pleiotropy 240 scores on average. Within eQTLs, we also observed significant correlations between our 241 pleiotropy score and the numbers of genes Finally, we found that variants that are eQTLs for genes whose orthologs are associated with 246 multiple measurable phenotypes in mice or yeast have higher pleiotropy scores, demonstrating 247 that our pleiotropy score is also related to pleiotropy in model organisms. 248
All these results are consistent when using the Polygenicity/LD-corrected pleiotropy score 249 (ܲ and ܲ ሻ , indicating that the association of pleiotropy with molecular and biological function is 250 not exclusively driven by highly polygenic architecture (Additional File 1). 251 proteins regulating transcription and chromatin state, suggesting that these are the functions 272 that exhibit horizontal pleiotropy beyond the baseline level induced by polygenicity. The role of 273 these novel loci and these biological processes in human genetics and biology may be a fruitful 274 area for future study, with the potential for biological discovery. 275
Genome-wide pleiotropy study identifies novel biological loci
Pleiotropic loci replicate in independent GWAS datasets 276
As replication datasets, we used two additional sources of GWAS summary statistics to 277 calculate our LD-corrected pleiotropy score (ܲ and ܲ ): previously published GWASs and 278 meta-analyses for 73 human complex traits and diseases, which we collected and curated 279 manually from the literature (Methods, Supplementary Table 3 
) (24); and a previously 280
published study of 430 blood metabolites measured in 7,824 European adults (25). For all 281 variants covered by the UK Biobank, we were able to compute our pleiotropy score 282 independently using these two datasets (Figure 7) . In the traits and diseases dataset, we 283 observed that 57% of This high level of replication using independent sets of GWAS summary statistics suggests that 287 our pleiotropy score is capturing an underlying biological property, rather than an artifact of the 288 UK Biobank study. 289
Pleiotropy is correlated with specific complex traits and diseases 290
To characterize the phenotypic associations of these loci, we used our replication dataset of 291 published GWAS summary statistics for 73 human quantitative traits and diseases, plus nine 292 additional traits we excluded from our replication dataset for a total of 82 (Methods). We are not 293 able to compute directly the degree of pleiotropy exhibited by these traits, since our definition of 294 horizontal pleiotropy applies only to individual variants and does not apply to traits. However, we 295 can identify traits whose GWAS variant associations are correlated to our pleiotropy score, 296 which in some sense represents the traits that contribute most to our signal of pervasive 297 horizontal pleiotropy. Figure 6c shows the correlations between our LD-corrected pleiotropy 298 score (ܲ and ܲ ) and the association statistics for these 82 traits and diseases. The most 299 strongly correlated traits were anthropometric traits like body mass index, waist and hip 300 circumference, and height; certain blood lipid levels, including total cholesterol and triglycerides; 301 and schizophrenia. These are all known to be highly polygenic and heterogeneous traits. The 302 least correlated traits include several measurements of insulin sensitivity and glucose response, 303 such as the insulin sensitivity index (ISI), certain features of brain morphology, and the 304 inflammatory biomarker lipoprotein(a). This may be partly due to low sample size of the 305 corresponding GWASs. However, these correlations do not appear to be driven exclusively by 306 sample size: in cases where multiple GWASs for the same trait have been performed on 307 subsamples of the population (for example, males only, female only, and combined), the sample 308 size only marginally affects the correlation ( Supplementary Table 4 ). Another contributing 309 factor may be heritability: height, in particular, is among the most heritable traits we examined, 310 while ISI and the brain morphology features are among the least. 311
Discussion
312
We have presented a framework for scoring horizontal pleiotropy across human genetic 313 variation. In contrast to previous analyses, our framework explicitly distinguishes between 314 horizontal pleiotropy and vertical pleiotropy or biological causation. After applying both 315 components of our pleiotropy score to 372 heritable medical traits from the UK Biobank, we 316 made the following observations: 1) horizontal pleiotropy is pervasive and widely distributed 317 across the genome; 2)) horizontal pleiotropy is driven by extreme polygenicity of traits; 3) 318 horizontal pleiotropy is significantly enriched in actively transcribed regions and active regulatory 319 regions, and is correlated with the number of genes and tissues for which the variant is an 320 eQTL; 4) there are thousands of loci that exhibit extreme levels of horizontal pleiotropy, a 321 majority of which have no previously reported associations; and 5) pleiotropic loci are enriched 322 in specific complex traits including body mass index, height, and schizophrenia. These findings 323 are largely consistent between the magnitude of pleiotropy score ܲ and the number of traits 324 score ܲ , although we note some differences where some variants are primarily associated with 325 ܲ but not ܲ . This indicates that these signals are driven by loci that both influence a large 326 number of traits and have relatively large combined effects, and secondarily by loci that have 327 large combined effects but only influence a handful of traits each, with minimal contribution from 328 loci that influence a large number of traits but have small combined effects. Conversely, after 329 applying the correction for polygenicity, we only observe variants that are significant for ܲ , but 330 not for ܲ . This indicates that, while there do exist horizontal pleiotropic master control loci that 331 affect more traits than we would expect from the random overlap of multiple highly polygenic 332 traits, the overall effect of these loci is not noticeably larger than we would expect. 333 This analysis is enabled by the technique of whitening trait associations to remove correlations 334 between traits. This lets us count pleiotropic effects in a more objective and systematic way, as 335 opposed to manually selecting putatively independent traits to count, or manually grouping traits 336 into independent blocks. However, it does come with three major limitations compared to these 337 approaches. First, it is somewhat more difficult to tell which specific traits are driving a signal of 338 pleiotropy at a particular locus. Our whitened traits are combinations of real observed traits, and 339 do not necessarily correspond to any specific biological traits of interest. However, it is relatively 340 easy to inspect the input GWAS summary statistics for a particular variant of interest to see 341 which traits it is associated with. Furthermore, since pleiotropic loci are by definition associated 342 with a large cross-section of traits, this kind of inspection is not likely to be very informative 343 about specific traits. Second, the whitening procedure has the counterintuitive property that a 344 variant that has a narrow effect on a single trait without also affecting correlated traits can 345 appear to be highly pleiotropic. For example, if a variant had a strong risk-increasing effect on 346 coronary artery disease (CAD), but no effect on any of the known upstream risk factors of CAD 347 (such as blood lipid levels or adiposity) or any of the known downstream consequences of CAD 348 (such as inflammatory biomarkers or increased mortality), such a variant would appear as highly 349 pleiotropic in our analysis. Our analysis would interpret the variant as increasing the risk of CAD 350 while suppressing these upstream and downstream factors. We believe this treatment is 351 appropriate, however counterintuitive. Regardless, these kinds of isolated effects are fairly rare: 352 in our dataset of 372 heritable traits from UK Biobank, only 6% of variants (42,684 of 767,057) 353 reach genome-wide significance for only a single trait. Indeed, it is unlikely by definition that a 354 variant is associated with only one trait from a set of correlated traits, since we compute our 355 correlations from observed association statistics. Third, we assume all genetic effects are 356 additive and independent, and we do not model epistasis or other more complex genetic 357
architectures. 358
Our findings are in keeping with several recent studies that have found abundant pleiotropy in 359 the genome (26,27,8,2,9). Our pleiotropy score goes a step further than many of these studies 360 by explicitly removing vertical pleiotropy between traits, which are indicative of fundamental 361 biological relationships between traits (8,24,28). Furthermore, the current study has evaluated 362 horizontal pleiotropy in human genetic variation genome-wide, whereas previous studies have 363 focused on only a small subset of disease-associated variants identified from GWAS. Our 364 results therefore suggest that there is substantial complexity and heterogeneity not only in 365 causal relationships between human traits, but also in the genetic architecture of individual 366 traits. 367
Our findings have several important implications for the field of human genetics. First, our 368 observation of ubiquitous horizontal pleiotropy is problematic for Mendelian Randomization 369 (MR) methods, which assumes horizontal pleiotropy to be absent. Recent developments in the 370 field of MR include methods that account for horizontal pleiotropy explicitly (24,28,29); our 371 results reinforce the importance of these methods. The presence of widespread horizontal 372 pleiotropy suggests that single-instrument methods that independently account for every variant, 373 each of which presumably has pleiotropic effects on many different distinct traits, should be 374 considered in addition to multi-instrument methods for MR, which collapse many variants into a 375 single polygenic score for analysis, and therefore treat all variants equivalently. 376
Second, our results appear to support the "network pleiotropy" hypothesis of Boyle, Li, and 377 Pritchard (16), which proposes widespread pleiotropy driven by small perturbations of densely 378 connected functional networks, where any perturbation in a relevant cell type will have at least a 379 small effect on all phenotypes affected by that cell type. A subsequent paper detailed a more 380 specific mechanism, where causal effects are driven by many biological components that are 381 only indirectly related to the phenotype itself (30). Many of the functional enrichments we 382 observe, including transcription factors, cytoskeleton, and intracellular signaling cascades, 383 represent components that can plausibly influence a wide variety of cell types and processes, 384
providing evidence for this model over one where a specific biological component is largely 385 responsible for pleiotropy. The fact that the magnitude of pleiotropy score ܲ and the number of 386 traits score ܲ give largely consistent results also supports this model, where a larger biological 387 effect in a given tissue will perturb a greater number of phenotypes relevant to that tissue, 388 although we note that some variants have high magnitude of pleiotropy score ܲ and low 389 number of traits score ܲ , which may represent a small class of variants that has large biological 390 effects without perturbing a large number of phenotypes. 391
While our results largely support this network pleiotropy hypothesis, we have also demonstrated 392
an alternate view of horizontal pleiotropy in the context of highly polygenic causation. In our 393 simulations, introducing extreme polygenicity at the levels suggested by these papers inherently 394 results in high levels of horizontal pleiotropy detectable by our score, independent of any 395 assumptions about the mechanism of pleiotropy or of polygenicity. Indeed, our null hypothesis 396 of no horizontal pleiotropy, that 5% of the genome is independently causal to each trait with P < 397 0.05, is trivially rejected when a single trait is influenced by an unexpectedly large fraction of the 398 genome. This means that, on some level, widespread horizontal pleiotropy in human genetic 399 variation is simply a logical consequence of widespread polygenicity of human traits, regardless 400 of the specific mechanism of either. In simple terms, the more loci are associated with each trait, 401 the more chances there are for associations with multiple traits to overlap. Supporting this 402 result, we find that controlling for the polygenic architecture of the input traits significantly 403 attenuates our signal of pleiotropy, as does restricting to oligogenic traits. It may be the case 404 that horizontal pleiotropy is only truly widespread among the most complex and polygenic 405 subset of human traits. 406
Conclusions
407
In this study, we have presented a quantitative score for horizontal pleiotropy in human genome 408 variation. Using this score, we have identified a genome-wide trend of highly inflated levels of 409 horizontal pleiotropy, an underappreciated relationship between horizontal pleiotropy with 410 polygenicity and functional biology, and a large number of specific novel loci with high levels of 411 horizontal pleiotropy. We expect further investigations using this score to yield deep insights into 412 the genetic architecture of human traits and to uncover important novel biology. 413
Methods
414
We developed a statistical method to measure horizontal pleiotropy using a two-component 415 pleiotropy score. For a given variant, we measured 1) the total magnitude of pleiotropic effect 416 the variant has and 2) the number of whitened traits affected by the variant. 417
Z-scores decorrelation strategy 418
Observable traits and diseases can be highly correlated, which can lead to inflation of our 419 pleiotropy score if the correlation is not properly accounted for. Therefore, we developed an 420 efficient strategy to remove this correlation and obtain decorrelated traits. Let
ܼ ௪
denote the 421 matrix of raw Z-scores, with variants in columns and traits in rows, and Computation of the pleiotropy score 439 We computed two different scores to capture both the magnitude and number of traits of 440 pleiotropy. First, we quantify the total pleiotropic magnitude of effect a variant using the 441 magnitude pleiotropy score given by the fraction of permuted variants with higher scores than the given value. We 469 converted these P-values into polygenicity/LD-corrected Simulations were run for all combinations of the following parameters: 1) correlation structure: 481 absent or present; 2) proportion of pleiotropic causal variants: 0.1% (800/800,000 variants) or 482 1% (8,000/800,000 variants); 3) proportion of non-pleiotropic causal variants: 0 (0/800,000 483 variants), 0.1% (800/800,000 variants), or 1% (8,000/800,000 variants); 4) number of traits 484 First, we retrieved GWA publicly available summary statistics from 545 continuous traits in 489 361,194 samples from the UK Biobank (17), and 1,403 binary traits from the same dataset 490 calculated using SAIGE (18, 19) . We used LD score regression to calculate heritability for each 491 trait, using the liability scale for binary traits, and restricted the sample to only traits with a 492 significant P-value for nonzero heritability after Bonferroni correction. For every pair of traits with 493 correlation coefficient between Z-scores ‫ݎ‬ ଶ 0 . 8
Computation of theoretical P-values for the pleiotropy score
, we additionally removed the member of the 494 pair with lower heritability. This left a total of 372 traits. 495
Second, we retrieved publicly available genome-wide association (GWA) summary statistics 496 data for 82 complex traits and diseases (31-66) ( Table S9) . For each dataset, we retrieved the 497 appropriate variant annotation (build, rsid, chromosome, position, reference and alternate 498 alleles) and summary statistics (effect size, standard errors, P-values and sample size of the 499 study). All variant coordinates (chr, pos) were lifted over to hg19 using the UCSC Genome 500
Browser LiftOver Tool and aligned to the reference and alternate alleles retrieved from the 501 Ensembl variation database. After performing the same pruning of highly correlated phenotypes, 502
we were left with 73 traits and diseases. 503 Third, we retrieved GWA summary statistics datasets from a GWAS of 453 blood metabolites in 504 7,824 individuals (67). After performing the same pruning of highly correlated phenotypes, we 505 were left with 430 metabolites. 506
Genome-wide pleiotropy study (GWPS)
507
Using the two components of the pleiotropy score, we can run a genome-wide pleiotropy study 508 (GWPS) which consists of computing two P-values for each component of the score (ܲ and 509 ܲ ) and for all variants genome-wide. We computed the pleiotropy score separately for each of 510 the three datasets described above (372 UK Biobank phenotypes, 73 traits and diseases, and 511 430 blood metabolites). Additionally, we computed the pleiotropy score on a subset of 372 traits 512 with genome-wide significant heritability as calculated by LD Score Regression (20) (univariate 513 heritability significant after Bonferroni correction). The 372 UK Biobank heritable traits were 514 used for discovery, and the 73 traits and diseases and 430 blood metabolites datasets were 515 used for replication. There was a total of 768,756 variants genotyped across all three datasets. 516
Study of polygenicity on horizontal pleiotropy 517
To study the effect of polygenicity on horizontal pleiotropy, we first estimated the liability-scale 518 heritability of all 372 traits in our UK Biobank dataset using LD score regression, and stratified 519 all traits into four equally-sized classes of heritability, in order to control for the effect of high 520 heritability separate from the effect of high polygenicity. Next, we estimated the polygenicity of 521 the 372 traits using a corrected version of the genomic inflation factor ߣ ீ (20) . The intercept of 522 LD score regression minus one is an estimator of the mean contribution of confounding bias to 523 the inflation in the test statistics. Therefore, we computed a corrected version of the genomic 524 inflation factor by subtracting the quantity (intercept of LD score regression -1) from ߣ ீ . The 525 372 phenotypes were then ranked according to ߣ ீ within each heritability class, and grouped 526 into 5 equal-sized bins of about 20 phenotypes each. We then recomputed the LD-corrected 527 pleiotropy score components (ܲ and ܲ ) for the subset of phenotypes in each bin. The 528 inflation of the pleiotropy score was measured per bin to represent pleiotropy score inflation as a 529 function of polygenicity. 530 531 We performed various enrichment analyses for the pleiotropy score to characterize the 532 pleiotropic variants using a variety of annotations that could be a direct consequence of 533 horizontal pleiotropy. Each analysis uses the principle of assigning each variant an annotation 534 category and selecting one category as the reference category. Then, for each category, we 535 selected a set of variants from the corresponding reference category with minor allele 536 frequencies matched to those in the query category, and performed a Student's t-test to test 537 whether the average LD-corrected pleiotropy score (ܲ and ܲ ) of the variants in each given 538 category is different from the average LD-corrected pleiotropy score of the selected reference 539 variants. 540
Characterization of the pleiotropic variants
First, we used Ensembl Variant Effect Predictor (21) to classify each variant as noncoding, UTR, 541 nonsynonymous, or coding synonymous, treating noncoding as the reference class. These were 542 complemented by annotations from Roadmap Epigenomics (22). We used the 25-state 543 chromatin state model published by Roadmap Epigenomics to assign each variant 25 scores 544 from 0 to 127, where each score represents the number of epigenomes for which that site is 545 assigned to the corresponding category. We did the same for two specific chromatin marks: the 546 activating mark H3K27ac and the repressive mark H3K27me3. For these annotations, we used 547 a combination of all other categories as a reference set. In other words, the reference set for 548 each category is all variants that are not in that category. 549
In addition to these molecular annotations, we used expression-related annotations from the 550 Genotype-Tissue Expression project (23). For each variant, we retrieved the number of genes 551 for which the variant is referenced as a cis eQTL (expression quantitative trait loci) in any tissue 552 (eGenes), and the number of tissues where the variant is annotated as a cis eQTL for any gene 553 (eTissues). We divided variants into bins by number of eGenes (below 10, between 10 and 15, 554 between 15 and 20, and over 20) and eTissues (below 30, between 30 and 35, between 35 and 555 40, and above 40). The reference set used for these analyses were variants that are not 556 annotated as eQTLs in any gene or tissue. 557
Finally, we used model organism phenotypes measured by the International Mouse 558
Phenotyping Consortium (IMPC) (68) and the Saccharomyces Cerevisiae Morphological 559 Database (SCMD) (69). To map ortholog genes from IMPC and SCMD to human variants, we 560 used orthology annotations of gene orthologs, and eQTLs from GTEx. Thus, variants annotated 561 as associated with a mouse or yeast phenotype are those that are annotated as cis eQTLs in 562 any tissue for a gene whose ortholog in mouse or yeast is associated with that phenotype. The 563 reference set for this analysis was variants annotated as cis eQTLs for genes that are not 564 associated with mouse or yeast phenotypes. 565
Genome-wide significant pleiotropy loci 566
To detect loci with a genome-wide significant pleiotropy, we used the LD-corrected two-567 component pleiotropy score (ܲ and ܲ ) computed on the dataset of 372 heritable traits from 568 UK Biobank described above. We used LD clumping as implemented in PLINK to cluster linked 569 variants, with an ‫ݎ‬ ଶ threshold of 0.1, a distance threshold of 100 kb, and P-value thresholds of 5 570
x 10 -8 for genome-wide significance and 0.05 for nominal significance. The resulting loci were 571 assigned to genes using 1) localization of variants within a gene, as annotated by Ensembl 572
Variant Effect predictor, and 2) annotation as a cis eQTL in any tissue, as annotated by GTEx. 573
We submitted the resulting list of genome-wide significant genes to DAVID for enrichment 574 analysis (70-72). 575
Permutation-based null model for replication analysis 576 In general, we should expect only 5% of loci to replicate by chance in each replication dataset; 577 however, it is possible that this number might increase because of polygenicity in the underlying 578 GWAS statistics and the resulting inflation in our pleiotropy score, which may cause 579 substantially more than 5% of the genome to be assigned P < 0.05. To correct for this, we 580 performed random permutations of the whitened Z-scores independently for each trait and used 581 these permuted Z-scores to compute our LD-corrected pleiotropy score components (ܲ and 582 ܲ ). This generates a null expectation that preserves the polygenicity and inflation within each 583 dataset. For both datasets, our null model expected that 5% of loci for ܲ loci and 6% of loci for 584 ܲ should replicate. The fraction that replicated in the actual data was substantially higher 585 (Figure 7) . Availability of data and material 592 An R package implementing this pleiotropy score method is available on GitHub at 593 https://github.com/rondolab/PleiotropyScore. The dataset of summary statistics for the 372 594 medical traits from the UK Biobank and the pleiotropy scores computed from these summary 595 statistics are also available in the same GitHub project at 596 https://github.com/rondolab/PleiotropyScore/tree/master/data. The summary statistics for 430 597 blood metabolites are available from the original publication where this dataset was reported 598 (61), and the summary statistics for 73 human traits and diseases are available from the original 599 publications where they were reported, as cited in Supplementary Table 3 . 0.0002 to 0.2, proportion of non-pleiotropic causal loci ranging from 0 to 1%, and proportion of 847 pleiotropic causal loci ranging from 0.1% to 1%. Our method has good power to detect 848 pleiotropy for highly heritable traits, though its power is reduced by extreme polygenicity. 849
Extreme polygenicity also increases the false positive rate, though this effect is corrected by our 850 polygenicity correction. 851 diseases. Contribution of pleiotropic variants is calculated as the correlation coefficient between 869 the absolute value of Z-scores and the pleiotropy score among variants that are genome-wide 870 significant for the pleiotropy score (P < 5 × 10 -8 for ܲ and ܲ respectively). 871 We used 372 UK Biobank heritable medical traits as our discovery dataset, and independent 873 datasets of 73 complex traits and diseases and 430 blood metabolites as replication datasets. In 874 each case, expected fraction of replication was empirically determined using a permutation 875 analysis. 876 37 Tables 877 
879
We grouped variants by (i) molecular function as annotated by Ensembl, (ii) predicted chromatin state as annotated by the NIH 880 Roadmap Epigenomics Project, (iii) transcriptional effects as annotated by the NIH Genotype-Tissue Expression (GTex) Project, and 881 (iv) effects on model organism phenotypes as annotated by the International Mouse Phenotyping Consortium (IMPC) and 882
